Bellevue Group »

Billiontoone Inc Cl A shares owned by Bellevue Group

Quarter-by-quarter ownership of Billiontoone Inc Cl A (BLLN) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Billiontoone Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including Billiontoone Inc Cl A held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Billiontoone Inc Cl A by Bellevue Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $867k 11k 81.84

More positions owned by Bellevue Group

Revolution Medicines (RVMD)
Argenx Se Sponsored Adr (ARGX)
Ionis Pharmaceuticals (IONS)
Vertex Pharmaceuticals Incorporated (VRTX)
Neurocrine Biosciences (NBIX)
Avidity Biosciences Ord (RNA)
Intuitive Surgical Com New (ISRG)
Scholar Rock Hldg Corp (SRRK)
Alnylam Pharmaceuticals (ALNY)
Abbott Laboratories (ABT)
Amicus Therapeutics (FOLD)
Boston Scientific Corporation (BSX)
Miragen Therapeutics (VRDN)
Stryker Corporation (SYK)
Nuvalent Inc-a (NUVL)

View all positions for Bellevue Group

Top funds holding Billiontoone Inc Cl A

Adams Street Partners
Baillie Gifford & Co
Neuberger Berman Group
NVP Associates
Vanguard Group
Napean Trading & Investment
Ubs Global Asset Management Americas
Invesco
Emerald Advisers
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Ameriprise Financial
Emerald Mutual Fund Advisers, Trust
T. Rowe Price Investment Management
Siren

View all funds holding Billiontoone Inc Cl A